WallStSmart

Gevo Inc (GEVO)vsLinde plc Ordinary Shares (LIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Linde plc Ordinary Shares generates 19769% more annual revenue ($34.65B vs $174.42M). LIN leads profitability with a 20.4% profit margin vs -19.4%. LIN earns a higher WallStSmart Score of 62/100 (C+).

GEVO

Hold

40

out of 100

Grade: D

Growth: 8.0Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 4/9Altman Z: -0.22

LIN

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 3.3Quality: 4.0
Piotroski: 3/9Altman Z: 1.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GEVO.

LINSignificantly Overvalued (-76.9%)

Margin of Safety

-76.9%

Fair Value

$299.52

Current Price

$529.79

$230.27 premium

UndervaluedFair: $299.52Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEVO2 strengths · Avg: 10.0/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
47.5%10/10

Revenue surging 47.5% year-over-year

LIN3 strengths · Avg: 9.0/10
Market CapQuality
$242.99B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
20.4%9/10

Keeps 20 of every $100 in revenue as profit

Operating MarginProfitability
28.5%8/10

Strong operational efficiency at 28.5%

Areas to Watch

GEVO4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$365.12M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-7.5%2/10

ROE of -7.5% — below average capital efficiency

Free Cash FlowQuality
$-30.02M2/10

Negative free cash flow — burning cash

LIN4 concerns · Avg: 3.3/10
PEG RatioValuation
2.234/10

Expensive relative to growth rate

P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : GEVO

The strongest argument for GEVO centers on Price/Book, Revenue Growth. Revenue growth of 47.5% demonstrates continued momentum.

Bull Case : LIN

The strongest argument for LIN centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 28.5%.

Bear Case : GEVO

The primary concerns for GEVO are EPS Growth, Market Cap, Return on Equity.

Bear Case : LIN

The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

GEVO profiles as a hypergrowth stock while LIN is a mature play — different risk/reward profiles.

GEVO carries more volatility with a beta of 0.99 — expect wider price swings.

GEVO is growing revenue faster at 47.5% — sustainability is the question.

LIN generates stronger free cash flow (898M), providing more financial flexibility.

Bottom Line

LIN scores higher overall (62/100 vs 40/100), backed by strong 20.4% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Gevo Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Gevo, Inc. is a renewable fuel company. The company is headquartered in Englewood, Colorado.

Visit Website →

Linde plc Ordinary Shares

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.

Visit Website →

Want to dig deeper into these stocks?